Novel outcome measures for Charcot−Marie−Tooth disease: validation and reliability of the 6‐min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Neurology

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ene.13033PMID 27160471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rehabilitation interventions for foot drop in neuromuscular disease.

  2015cited by this paper
• Responsiveness of clinical outcome measures in Charcot−Marie−Tooth disease

  2015cited by this paper
• CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis

  2014cited by this paper
• A pilot study of proximal strength training in Charcot‐Marie‐Tooth disease

  2014cited by this paper
• Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal study.

  2013cited by this paper
• THE 6-MINUTE WALK TEST AND OTHER ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: LONGITUDINAL NATURAL HISTORY OBSERVATIONS OVER 48 WEEKS FROM A MULTICENTER STUDY

  2013cited by this paper
• Outcome Measures and Rehabilitation Treatment in Patients Affected by Charcot‐Marie‐Tooth Neuropathy: A Pilot Study

  2011cited by this paper
• Natural history of Charcot–Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life

  2010cited by this paper
• The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy

  2010cited by this paper
• Ambulatory Activity of Stroke Survivors: Measurement Options for Dose, Intensity, and Variability of Activity

  2009cited by this paper
• Measuring distance walked and step count in children with cerebral palsy: an evaluation of two portable activity monitors.

  2009cited by this paper
• Diagnosis, natural history, and management of Charcot-Marie-Tooth disease.

  2009cited by this paper
• Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy

  2009cited by this paper
• Improving community ambulation after stroke: the AMBULATE trial

  2009cited by this paper
• Walking capacity evaluated by the 6‐minute walk test in spinal and bulbar muscular atrophy

  2008cited by this paper
• Daily ambulatory activity levels in idiopathic Parkinson disease.

  2008cited by this paper
• Experimental therapeutics in hereditary neuropathies: The past, the present, and the future

  2008cited by this paper
• Neuropathy progression in Charcot-Marie-Tooth disease type 1A

  2008influential reference
• Natural history of CMT1A including QoL: a 2-year prospective study.

  2008cited by this paper
• Clinical features of late‐onset Pompe disease: A prospective cohort study

  2008cited by this paper
• Reliability of clinical outcome measures in Charcot-Marie-Tooth disease.

  2008cited by this paper
• Correlation between clinical/neurophysiological findings and quality of life in Charcot‐Marie‐Tooth type 1A

  2008cited by this paper
• Rehabilitation interventions for foot drop in neuromuscular disease.

  2007cited by this paper
• Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy.

  2007cited by this paper
• Step Activity Monitor: accuracy and test-retest reliability in persons with incomplete spinal cord injury.

  2007cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].

  2006cited by this paper
• The relation between walking capacity and clinical correlates in survivors of chronic spinal poliomyelitis.

  2006cited by this paper
• Reliability and validity of the CMT neuropathy score as a measure of disability

  2005influential reference
• Influence of foot pain on walking ability of diabetic patients.

  2004cited by this paper
• ATS statement: guidelines for the six-minute walk test.

  2002cited by this paper
• Step activity monitor: long-term, continuous recording of ambulatory function.

  1999cited by this paper
• The Italian SF-36 Health Survey: translation, validation and norming.

  1998influential reference
• Epidemiology of peripheral neuropathy.

  1997cited by this paper

• Charcot–Marie–Tooth disease and related neuropathies

  2026cites this paper
• Clinimetría en polineuropatías

  2025cites this paper
• Is gaitrite system sensitive in discriminating gait pattern of subjects affected by Charcot Marie tooth? A pilot study

  2025cites this paper
• Clinical Characteristics of Gait Disturbance in Charcot-Marie-Tooth Disease and Future Directions in Physical Therapy

  2025cites this paper
• Walking test outcomes in adults with genetic neuromuscular diseases: a systematic literature review of their measurement properties

  2024cites this paper
• Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A

  2023cites this paper
• The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature review

  2023cites this paper
• Playing Disability Rugby League with Charcot-Marie-Tooth Disease: A Case Study

  2023cites this paper
• The mSteps pilot study: Analysis of the distance walked using a novel smartphone application in multiple sclerosis

  2022cites this paper
• A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice

  2022cites this paper
• Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies

  2021cites this paper
• Technology outcome measures in neuromuscular disorders: A systematic review

  2021cites this paper
• Contactless tracking of humans using non-contact triboelectric sensing technology: Enabling new assistive applications for the elderly and the visually impaired

  2021cites this paper
• High-density surface electromyography to assess motor unit firing rate in Charcot-Marie-Tooth disease type 1A patients.

  2021cites this paper
• The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis

  2020cites this paper
• Brain Plasticity in Charcot-Marie-Tooth Type 1A Patients? A Combined Structural and Diffusion MRI Study

  2020cites this paper
• Outcome measures in the clinical evaluation of ambulatory Charcot-Marie-Tooth 1A subjects.

  2019cites this paper
• 6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR).

  2019cites this paper
• Treadmill training in patients affected by Charcot–Marie–Tooth neuropathy: results of a multicenter, prospective, randomized, single‐blind, controlled study

  2019cites this paper
• Limitations in daily activities and general perception of quality of life: Long term follow‐up in patients with anti‐myelin‐glycoprotein antibody polyneuropathy

  2019cites this paper
• Aktuelles zur Charcot-Marie-Tooth-Erkrankung

  2019cites this paper
• Are novel outcome measures for Charcot-Marie-Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study.

  2019cites this paper
• Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies

  2019cites this paper
• Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP

  2019cites this paper
• Motor performance deterioration accelerates after 50 years of age in Charcot‐Marie‐Tooth type 1A patients

  2018cites this paper
• Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies

  2018cites this paper
• New developments in Charcot–Marie–Tooth neuropathy and related diseases

  2017cites this paper
• Advances and insights into neurological practice 2016−17

  2017cites this paper
• Efficacy of focal mechanic vibration treatment on balance in Charcot-Marie-Tooth 1A disease: a pilot study

  2016cites this paper
• Sport activity in Charcot–Marie–Tooth disease: A case study of a Paralympic swimmer

  2016cites this paper